Table II.
Virulence factors | Clinical outcomes | Mediators | Refs |
---|---|---|---|
PSM-alpha | Skin inflammation | IL-17A signalling | (60, 70) |
Skin barrier disruptions | Protease activity | ||
Delta-toxin | Skin inflammation | IL-4 signalling | (62, 71) |
Mast cell degranulation IgE release | |||
IgE release | |||
Alpha-haemolysin | Skin barrier disruptions | Keratinocyte lysis | (61) |
Enterotoxin B | Skin inflammation | T-cell signalling | (72) |
Clumping factor B | S. aureus colonization | Cell adherence | (79) |
PSM: phenol-soluble modulin; IL: interleukin.